Search Results 1211-1220 of 18598 for hepatitis

1. Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch - Mayo Clinic

   * Known HIV or active Hepatitis B/C * Clinically significant liver disease (Primary Sclerosing Cholangitis with LFT's \<1.5 upper limit of normal can be ...

2. A Study of the Safety and Effectiveness of Atezolizumab Combined with Etoposide, and Carboplatin for Patients with Untreated Extensive-Stage Small Cell Lung Cancer - Mayo Clinic

   Active hepatitis B or hepatitis C; Severe infections at the time of enrollment; Significant cardiovascular disease; Prior treatment with cluster of ...

3. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies - Mayo Clinic

   ... hepatitis B surface antigen [antiHBs]) must be screened using real-time polymerase chain reaction (PCR) measurement of hepatitis B virus (HBV) DNA levels.

4. Liver transplant - Care at Mayo Clinic

   Alcoholic hepatitis · Amyloidosis · Autoimmune hepatitis · Cholangiocarcinoma (bile duct cancer) · Cirrhosis · Esophageal varices · Hepatic encephalopathy ...

5. ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack - Mayo Clinic

   -Known (acute or chronic) hepatitis B or hepatitis C -History or evidence of untreated latent tuberculosis (TB) such as (but not limited to): a) History of ...

6. Home Care Treatment With Oral Chemotherapy For Recurrent Or Metastatic Oral Cavity Cancer - Mayo Clinic

   Known hepatitis. Exception: For patients with evidence of chronic hepatitis B virus infection the HepB viral load must be undetectable on suppressive therapy ...

7. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

   Has a known history of hepatitis B (defined as hepatitis ... Note: No testing for hepatitis B or hepatitis C is required unless mandated by local health authority ...

8. A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With MM - Mayo Clinic

   Has known active Hepatitis B (e.g., Hepatitis B Surface Antigen [HBsAg] reactive) or Hepatitis C (e.g., Hepatitis C Virus [HCV] RNA [qualitative] is detected).

9. Study to Assess the Effectiveness and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone to Treat Patients with Previously Treated Non-Hodgkins Lymphoma - Mayo Clinic

   Evidence of chronic active Hepatitis B (HBV) as evidenced by a detectable hepatitis B surface antigen (not including subjects with prior hepatitis B ...

10. Fidanacogene elaparvovec-dzkt (intravenous route) - Side effects & uses - Mayo Clinic

    Liver disease (eg, hepatitis B or C, non-alcoholic fatty liver disease, chronic alcohol consumption, and non-alcoholic steatohepatitis)—Use with caution.